Large clinical trials show that semaglutide can significantly reduce the risk of heart attack, stroke, and cardiovascular death in certain populations
[,] The buffering oxidant-antioxidant capacity of DFO has been found to endow a protective effect against lead-induced cardiotoxicity in rats
These substances are highly reactive and capable of causing damage to key cellular components and organelles, including lipids, nucleic acids, and proteins, leading to the onset of senescence [53, 54]
Saxenda, Enobosarm, VK2735, TERN-601, and ECC5004, among others GLP-1 agonists are a type of medication used primarily in the treatment of type 2 diabetes and sometimes for weight management